Report Overview

Indian Post-Operative Pain Management Therapeutics Market size stood at around USD XX Billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period.

Postoperative pain includes all type of acute pain that occurs due to injuries and can also resolve in appropriate healing period. Such pain often responds to analgesic medication and treatment of the precipitating cause. Postoperative pain can also cause cardiovascular, respiratory, endocrine, metabolic etc. Postoperative pain treatment evolved with different understanding of how drugs affect in our body when used in combinations. Opioids and Non-steroidal anti-inflammatory drugs are expected to contribute major share in terms of value to the overall postoperative pain market. Opioids act as a substance that acts on the opioid receptor to produce morphine like effects. They are most often used to relieve main. Non-steroidal anti-inflammatory drugs are used to treat pain, inflammation and fever.



Market Driving and Restraining Factors

Driving Factors

Rise in geriatric population, surge in prevalence of chronic diseases, such as cancer, diabetic neuropathy, and osteoarthritis propels the market growth, rise in healthcare expenditure, growth in awareness regarding diseases, enhancing healthcare infrastructure, research and development activities and surge in healthcare expenditure positively affect the pain management therapeutics market, rise in number of surgical procedures and rise in healthcare expenditure are expected to fuel growth of the post-operative pain management drugs market.

Restraining Factors

On the other hand, the restraining factors are the rising concerns regarding drug exploitation and patent expiration of prescription pain medication drugs are the factors expected to obstruct the post- operative pain management therapeutics market growth.